date:May 21, 2013
o many market categories.
Nitrosigine is an exciting addition to our ingredient division and we anticipate it will allow our customers to impact consumers in the sports nutrition, cardiovascular health and mens health categories, said Michael Satow, president and CEO of Nutrition 21. Nitrosigine also validates our ability to develop patent-protected NDIs.
Primary investigator, Dr. James C. Russell, Professor Emeritus, Department of Surgery, Metabolic and Cardiovascular Diseases Laboratory at t